Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes - Intern medicin: endokrinologi

Institut for Klinisk Medicin

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

J-P Courrèges
Vilsbøll, Tina
M Zdravkovic
Xuan Le Thi Thanh
T Krarup
Ole Schmitz
R Verhoeven
I Bugáñová
Madsbad, Sten

Originalsprog	Engelsk
Tidsskrift	Diabetic Medicine
Vol/bind	25
Udgave nummer	9
Sider (fra-til)	1129-31
Antal sider	3
ISSN	0742-3071
DOI	https://doi.org/10.1111/j.1464-5491.2008.02484.x
Status	Udgivet - 1 sep. 2008

ID: 34070364